Coverage
Metabolomics, the large-scale study of metabolites within cells, biofluids, tissues or organisms, is the definitive representation of the phenotype, providing a real-time assessment of health, wellness, and disease, whether influenced by genes, proteins, the environment, epigenetics, or the microbiome. Executed comprehensively, metabolomics provides life sciences researchers and drug developers with an integrated look at the functional state of a biological system, allowing you to quickly zero in on the biological insights and biomarkers that define health, disease, and treatment response.
Far too often, however, researchers and drug developers fail to benefit from the full power of metabolomics because they employ an incomplete metabolomics solution—one with limited coverage and interpretability—that leaves potentially transformational discoveries in the dark.
Poor Metabolomics Coverage Limits Biological Understanding
Reveal Metabolites, Not Peaks
Broad Coverage Leads to Actionable Insights
In contrast, Metabolon clients benefit from Metabolon’s informatics approach that relies on identifying LC/MS peaks based on a search of an in-house generated database of more than 5,400 biologically relevant small molecules. This compound database enables Metabolon to provide the greatest number of identified compounds with the highest possible confidence identifications in the industry; known as Metabolomics Standards Initiative. Metabolon’s broad coverage and adherence to the highest level of identification standards are crucial to understanding the biology and producing accurate, actionable insights. Read more about our approach to Level 1 metabolite identifications here.
See how Metabolon can advance your path to preclinical and clinical insights
Why Metabolon?
Once you see the full value of metabolomics, the only remaining question is who does it best? While many laboratories have metabolite profiling or analytical chemistry capabilities, comprehensive metabolomics technologies are extremely rare. Accurate, unbiased metabolite identification across the entire metabolome introduces signal-to-noise challenges that very few labs are equipped to handle. Also, translating massive quantities of data into actionable information is slow, if not impossible, for most because proper interpretation takes two things that are in short supply: experience and a comprehensive database.
Only Metabolon has all four core metabolomics capabilities
Coverage
Ability to interrogate thousands of metabolites across diverse biochemical space, revealing new insights and opportunities
Comparability
Ability to integrate the data from different studies into the same dataset, in different geographies, among different patients over time
Competency
Ability to inform on proper study design, generate high‐quality data, derive biological insights, and make actionable recommendations
Capacity
Ability to process hundreds of thousands of samples quickly and cost‐efficiently to service rapidly growing demand
Partner with Metabolon to access:
A library of 5,400+ known metabolites, 2,000 in human plasma, all referenced in the context of biochemical pathways
- That’s 5x the metabolites of the closest competitor
Unparalleled depth and breadth of experience analyzing and interpreting metabolomic data to find meaningful results
- 10,000+ projects with hundreds of clients
- 2,000+ publications covering 500 diseases, including numerous peer-reviewed journals such as Cell, Nature and Science
- Nearly 40 PhDs in data science, molecular biology, and biochemistry
Using our robust platform and visualization tools, our experts are uniquely able to tell you more about your molecule and develop assay panels to help you zero in on the results you need.
Related Metabolomics Resources
Contact Us
Talk with an expert
Request a quote for our services, get more information on sample types and handling procedures, request a letter of support, or submit a question about how metabolomics can advance your research.
Corporate Headquarters
617 Davis Drive, Suite 100
Morrisville, NC 27560
